Hint mode is switched on Switch off
For swift navigation between sections

MIRA Pharmaceuticals
LEI 5493000N6HPDY7V7OR15

PDF download

Choose all Reset all
Download Cancel
Organization name
MIRA Pharmaceuticals Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

MIRA Pharmaceuticals Inc is a life sciences company focused on the development of MIRA1a, a synthetic THC analog. MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and chronic pain without impurities or the negative side effects associated with cannabis plant extracts. MIRA1a is classified as an unscheduled drug by the U.S. Drug Enforcement Administration (DEA).

Awards

News

17/06/2026 MIRA Pharmaceuticals: Regulation Fd Disclosure, Financial Statements And Other Exhibits
02/06/2026 MIRA Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
21/05/2026 MIRA Pharmaceuticals: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
16/05/2026 AREC Earnings Preview: Delayed 10-K, Weak Liquidity, Critical Materials
13/05/2026 MIRA Pharmaceuticals: Regulation Fd Disclosure
All organization news

Documentation

IFRS/US GAAP reports

2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493000N6HPDY7V7OR15
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001904286
  • EIN
    85-3354547
Registration is required to get access.